CLINICAL IDENTIFICATION OF CIRRHOTIC CARDIOMYOPATHY

Cirrhotic cardiomyopathy (CCM) is a cardiac dysfunction associated with liver cirrhosis and characterized by impaired contractile response to stress, diastolic dysfunction, and electrophysiological abnormalities in the absence of primary cardiac disease. Early identification of cirrhotic cardiomyopathy remains a challenge in clinical practice because patients often demonstrate normal cardiac function at rest. The aim of this study was to evaluate clinical and instrumental markers for the early detection of cirrhotic cardiomyopathy in patients with liver cirrhosis. A clinical evaluation of patients with confirmed cirrhosis was performed, including echocardiography, electrocardiography, and biochemical testing. The results demonstrated that diastolic dysfunction, prolonged QT interval, and elevated levels of natriuretic peptides are common findings in patients with cirrhosis. Early recognition of cirrhotic cardiomyopathy is essential for improving patient prognosis, particularly in those undergoing liver transplantation.